Korean J Hematol.  2011 Dec;46(4):209-210. 10.5045/kjh.2011.46.4.209.

CXCR4 antagonists in hematologic malignancies: more than just mobilizers?

• Jo DY

• KMID: 2251978
• DOI: http://doi.org/10.5045/kjh.2011.46.4.209

Abstract

No abstract available.

Reference

1. Larochelle A, Krouse A, Metzger M, et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood. 2006; 107:3772–3778. PMID: 16439684.

2. Vose JM, Ho AD, Coiffier B, et al. Advances in mobilization for the optimization of autologous stem cell transplantation. Leuk Lymphoma. 2009; 50:1412–1421. PMID: 19603345.

3. DiPersio JF, Micallef IN, Stiff PJ, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol. 2009; 27:4767–4773. PMID: 19720922.

4. Laurence AD. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. Br J Haematol. 2006; 132:255–267. PMID: 16409290.

5. Zeng Z, Shi YX, Samudio IJ, et al. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood. 2009; 113:6215–6224. PMID: 18955566.

6. Tsutsumi H, Tanaka T, Ohashi N, et al. Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents. Biopolymers. 2007; 88:279–289. PMID: 17167792.

7. Juarez J, Bradstock KF, Gottlieb DJ, Bendall LJ. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia. 2003; 17:1294–1300. PMID: 12835717.

8. Tavor S, Eisenbach M, Jacob-Hirsch J, et al. The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia. 2008; 22:2151–5158. PMID: 18769446.

9. Beider K, Begin M, Abraham M, et al. CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp Hematol. 2011; 39:282–292. PMID: 21138752.

10. Kim HY, Hwang JY, Oh YS, et al. Differential effects of CXCR4 antagonists on the survival and proliferation on myeloid leukemia cells in vitro. Korean J Hematol. 2011; 46:244–252.